Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
16 January, 2019 12:18 IST
Alembic Pharma receives nod for Doxycycline Hyclate capsules
Source: IRIS | 14 Jun, 2018, 11.09AM
Comments  |  Post Comment

Alembic Pharmaceuticals today announced that the company has received approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Doxycycline Hyclate Capsules USP, 50 mg and 100 mg.

The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Vibramycin Capsules, 50 mg and 100 mg, of Pfizer Inc. Doxycycline is indicated for a wide variety of bacterial infections including those caused by several gram-negative as well as gram-positive microorganisms. Doxycycline is also indlcated for the prophylaxis of malaria due to Plasmodium falciparum in short-term travelers (<4 months) to areas with chloroquine and/or pyrimethaminesulfadoxine resistant strains. Doxycycline may be a useful adjunctive therapy in severe acne and in acute intestinal amebiasis.

Doxycycline Hyclate Capsules USP, 50 mg and 100 mg, have an estimated market size of USD 80 million for twelve months ending December 2017 according to IQVIA.

Alembic now has a total of 73 ANDA approvals (65 final approvals and 8 tentative approvals) from USFDA.

Shares of the company gained Rs 16.2, or 3.16%, to trade at Rs 529.00. The total volume of shares traded was 27,704 at the BSE (10.59 a.m., Thursday).





Alembic Pharmaceuticals Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Sector
Texmaco Rail & Engineering receives orders worth Rs 2.62 bn - 16-Jan-2019 12:59
Dr Reddys announces completion of USFDA audit of its formulation facility in Andhra Pradesh - 16-Jan-2019 10:15
HG Infra bags NHAI road project worth Rs 5.65 bn - 15-Jan-2019 10:29
L&T Hydrocarbon consortium wins EPCI order from Saudi Aramco - 15-Jan-2019 10:24
Zydus Cadila gets final approval from USFDA for 2 drugs - 15-Jan-2019 10:20
AGC Networks completes acquisition of Black Box Corporation - 10-Jan-2019 10:31
Glenmark Pharma enters into licensing agreement with Yuhan for commercializing Ryaltris in South Korea - 10-Jan-2019 10:28
IndusInd Bank Q3 net up 5%; Provisions grow 2.56 times - 09-Jan-2019 17:16
Tera Software secures work order worth Rs 3.24 bn - 09-Jan-2019 16:52
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer